1. Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study. Issue 1 (28th August 2014) Authors: Huizinga, T W J; Conaghan, Philip G; Martin-Mola, Emilio; Schett, Georg; Amital, Howard; Xavier, Ricardo M; Troum, Orrin; Aassi, Maher; Bernasconi, Corrado; Dougados, Maxime Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 1(2015) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of the Disease Activity Score in Twenty‐Eight Joints–Based Flare Definitions in Rheumatoid Arthritis: Data From a Three‐Year Clinical Trial. Issue 12 (December 2015) Authors: Dougados, Maxime; Huizinga, Tom W. J.; Choy, Ernest H.; Bingham, Clifton O.; Aassi, Maher; Bernasconi, Corrado Journal: Arthritis care & research Issue: Volume 67:Issue 12(2015:Dec.) Page Start: 1762 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P268 Impact of intermediate treatment interruption on secukinumab efficacy in patients with active psoriatic arthritis and ankylosing spondylitis: interim analysis results from the SERENA study. (23rd April 2022) Authors: Gaffney, Karl; Kiltz, Uta; Sfikakis, Petros; Gullick, Nicola; Katsifis, Gkikas; Kandili, Anna; Brandt-Juergens, Jan; Goupille, Phillipe; Maiden, Nicola; Aassi, Maher; Schulz, Barbara; Pournara, Effie; Jagiello, Piotr Journal: Rheumatology Issue: Volume 61(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis. (1st September 2022) Authors: Reich, Kristian; Baraliakos, Xenophon; Coates, Laura C.; Elewski, Boni; Bao, Weibin; Kasparek, Torben; Gaillez, Corine; Pournara, Effie; Aassi, Maher; Perella, Chiara; Gottlieb, Alice B. Journal: British journal of dermatology Issue: Volume 187:Number 3(2022) Page Start: 438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis. (7th June 2022) Authors: Reich, Kristian; Baraliakos, Xenophon; Coates, Laura C.; Elewski, Boni; Bao, Weibin; Kasparek, Torben; Gaillez, Corine; Pournara, Effie; Aassi, Maher; Perella, Chiara; Gottlieb, Alice B. Journal: British journal of dermatology Issue: Volume 187:Number 3(2022) Page Start: 438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Treatment of Rheumatoid Arthritis With Anti–Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic Agent in a Global Comparative Observational Study. Issue 10 (6th September 2017) Authors: Choy, Ernest H.; Bernasconi, Corrado; Aassi, Maher; Molina, Jose Fernando; Epis, Oscar Massimiliano Journal: Arthritis care & research Issue: Volume 69:Issue 10(2017:Oct.) Page Start: 1484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗